GB/T 44651.2-2025Implementation guidances for knowledge management — Part 2: Pharmaceutical industry (English PDF)
知识管理实施指南 第2部分:制药
Open the GB/T 44651.2-2025 preview as PDF
This is a limited preview
Buy now to download the full PDF (17 pages)
Issued by
SAMR; SAC
Level / Type
National · Recommended
Issue date
August 29, 2025
Implementation date
March 1, 2026
Scope
GB/T 44651.2-2025 is the English-translated version of 知识管理实施指南 第2部分:制药.
GB/T 44651.2-2025 is the Chinese national standard covering knowledge management in a pharmaceutical company — the product and process knowledge that has to travel from development to manufacturing, the deviation and change history, the knowledge required by the quality system, and the capture and transfer that regulators expect to see documented. Part 2 of the series, under the National Intellectual Property Administration, with the electric power part GB/T 44651.3-2025. First edition, in force from 1 March 2026. Issued on 29 August 2025, it has been in force since 1 March 2026.
Document preview — GB/T 44651.2-2025
National Standard of the People's Republic of China
- ICS
- 03.100.30
- Classification
- A 00
Issued by: State Administration for Market Regulation; Standardization Administration of the PRC
Contents
- PrefaceIII
- IntroductionIV
- 1 Scope1
- 2 Normative references1
- 3 Terms and Definitions1
- 4 Organizational Environment2
- 4.1 Understanding the organization and its internal and external environment2
- 4.2 Understanding the needs and expectations of stakeholders3
- 4.3 Determine the scope of the knowledge management system3
- 4.4 Knowledge Management System3
- 5 Leadership3
- 5.1 Management Commitment3
- 5.2 Developing a knowledge policy4
- 5.3 Roles, responsibilities and authorities4
- 6 Planning4
- 6.1 Measures to address risks and opportunities4
- 6.2 Knowledge Objectives and Plans5
- 7 Support5
- 7.1 Resources5
- 7.2 Capabilities7
- 7.3 Consciousness7
- 7.4 Communication8
- 7.5 Documented information8
- 7.6 Document Information Management and Control8
- 8 Run8
- 8.1 Operational Planning and Control8
- 8.2 Product R&D8
- 8.3 Commercial production9
- 8.4 Marketing9
- 8.5 Operational Guarantee9
- 9 Performance Evaluation10
- 9.1 Monitoring and Evaluation10
- 9.2 Internal Audit10
- 9.3 Management Review10
- 10 Improvement11
- 10.1 Non-conformity control and corrective actions11
- 10.2 Continuous Improvement1112
- Appendix A (Informative) Knowledge Maintenance and Knowledge Base Classification12
- Reference13
Foreword
This document is in accordance with the provisions of GB/T 1.1-2020 "Guidelines for standardization work Part 1: Structure and drafting rules for standardization documents" Drafting.
This document is Part 2 of GB/T 44651 “Guidelines for the Implementation of Knowledge Management”. GB/T 44651 has been published in the following parts.
— Part 1: Equipment manufacturing industry;
— Part 2: Pharmaceuticals;
— Part 3: Electricity.
Please note that some of the contents of this document may involve patents. The issuing organization of this document does not assume the responsibility for identifying patents.
This document is submitted by the State Intellectual Property Office.
This document is under the jurisdiction of the National Technical Committee for Standardization of Knowledge Management (SAC/TC554).
This document was drafted by: Yangtze River Pharmaceutical Group Co., Ltd., China National Institute of Standardization, China Resources Biopharmaceutical Co., Ltd., Jiangsu Huiju Pharmaceutical Co., Ltd.
Pharmaceutical Co., Ltd., Jiangxi Quality and Standardization Research Institute, Jiangxi Kelun Pharmaceutical Co., Ltd., and Beijing Information Science and Technology University.
The main drafters of this document are: Xu Kaixiang, Yue Gaofeng, Wen Limin, Huang Yaru, Zhang Wei, Zhou Xiangshan, Wang Shumin, Cong Dezheng, Zou Ping, Gao Liang, Wen Na, Miao Yanhui, Xie Liang, Jin Chunhua, Huang Dong, Cai Junmin, and Zhang Weijuan.
Introduction
0.1 Overview
The pharmaceutical industry is a strategic industry that is related to the national economy and people's livelihood, economic development and national security, and is an important foundation for the construction of a healthy China.
R&D innovation is difficult, has a long cycle, high investment, and is knowledge-intensive. It is a typical high-tech industry. Knowledge management in the pharmaceutical industry runs through the pharmaceutical industry.
The pharmaceutical industry directly affects the development of life and health.
In order to promote the high-quality development of the pharmaceutical industry based on innovation, pharmaceutical companies It is necessary to implement knowledge management and plan and manage relevant knowledge resources and knowledge activities. ICHQ10 clearly states that pharmaceutical companies’ knowledge Knowledge management is one of the driving forces behind the development of an enterprise's quality system. As a special commodity, medicines are closely related to people's life and health.
The life cycle is long, including the process of drug research and development, registration evaluation, marketing, re-evaluation, and delisting.
The knowledge management level of production, operation, circulation and other links is closely related to the quality of drugs.
Develop and utilize the data and experience in the process, fully explore and discover knowledge, guide production and operation, assist decision-making, and promote organizational structure and business Optimize processes, improve management systems, and promote enterprise transformation, transformation and upgrading.
0.2 Process Approach
This document aims to promote technological innovation and value creation in the pharmaceutical industry.
Part 1: Under the guidance of the Guidelines, the ideas and methods for pharmaceutical companies to carry out knowledge management work are proposed, in product research and development, commercial production, market In each link of marketing, operation guarantee, etc., we plan and manage the activities of knowledge identification, creation, acquisition, storage, sharing, and application, and comprehensively Use emerging knowledge management technologies to spread the pursuit of continuous improvement and innovation awareness within the organization, and promote the organization's innovation capabilities and Improved competitiveness.
GB/T 44651 "Guidelines for the Implementation of Knowledge Management" aims to provide guidance for the implementation of knowledge management systems in different industries.
It consists of the following parts.
— Part 1: Equipment manufacturing industry. The purpose is to provide a general framework, methods and construction guidelines for knowledge management in the manufacturing industry.
— Part 2: Pharmaceuticals. Aims to provide a general framework, methods and construction guidelines for knowledge management in the pharmaceutical industry.
— Part 3: Electricity. The purpose is to provide a general framework, methods and construction guidelines for knowledge management in the power industry.
Knowledge Management Implementation Guide Part 2: Pharmaceuticals
1 Scope
This document provides information on leadership, planning, support, operation, performance evaluation and improvement in the process of knowledge management in pharmaceutical companies. implementation guide.
This document is applicable to the planning, establishment and evaluation of knowledge management systems in pharmaceutical companies, and can be used as a reference for other types of organizations.
2 Normative references
GB/T 19000-2016
GB/T 23703.2-2010
GB/T 34061.1-2017
3 Terms and Definitions
The terms and definitions defined in GB/T 19000-2016, GB/T 23703.2-2010 and GB/T 34061.1-2017 and the following terms and definitions apply For use in this document.
3.1 knowledge
Knowledge, judgment or skills acquired through learning, practice or exploration.
[Source. GB/T 23703.2-2010, 2.1]
3.2 knowledge management
Activities for planning and managing knowledge, the knowledge creation process and the application of knowledge.
[Source. GB/T 23703.2-2010, 2.9]
3.3 knowledgebase/repository
The collection of domain knowledge required to solve the problem, expressed as basic facts, rules and patterns organized into procedures, used for the relevant domain knowledge Capture, store, and share.
[Source. GB/T 23703.2-2010, 4.6]
3.4 Industry expert subject matter expert; SME
An expert who is proficient in a particular field or subject.
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 17 pages — is available in the English PDF.
Referenced standards
Normative references
- GB/T 23703.2-2010Knowledge management - Part 2: Terminology
- GB/T 34061.1-2017Knowledge management system—Part 1: Guidelines
GB/T 19000-2016
Editions of GB/T 44651.2
| Edition | Title | Revision | Status |
|---|---|---|---|
| GB/T 44651.2-2025 | Implementation guidances for knowledge management - Part 2: Pharmaceutical industry | current edition | Current |
This page sells the current edition, GB/T 44651.2-2025. Earlier editions are listed for reference only.
How to Buy GB/T 44651.2-2025
- 1Add to cart. Click the "Buy GB/T 44651.2-2025" button on this page. You can add more standards before checkout.
- 2Checkout. Enter your email and billing details. Payment is processed securely by Stripe (cards, Apple Pay, Google Pay supported).
- 3Instant delivery (0–9 sec). Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4Invoice included. A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 23703.2-2010 — Knowledge management - Part 2: Terminology
GB/T 34061.1-2017 — Knowledge management system—Part 1: Guidelines
GB/T 44651.1-2024 — Implementation guidances for knowledge management—Part 1: Equipment manufacturing
Secure payment via Stripe
Payments accepted
GB/T 44651.2-2025
$305.00